Display options
Cite
Gremmel T, Michelson AD, Wadowski PP, et al. Sex-specific platelet activation through protease-activated receptor-1 in patients undergoing cardiac catheterization. Atherosclerosis. 2021;339:12-19doi: 10.1016/j.atherosclerosis.2021.11.011.
Gremmel, T., Michelson, A. D., Wadowski, P. P., Pultar, J., Weikert, C., Tscharre, M., Lee, S., Panzer, S., & Frelinger, A. L. (2021). Sex-specific platelet activation through protease-activated receptor-1 in patients undergoing cardiac catheterization. Atherosclerosis, 33912-19. https://doi.org/10.1016/j.atherosclerosis.2021.11.011
Gremmel, Thomas, et al. "Sex-specific platelet activation through protease-activated receptor-1 in patients undergoing cardiac catheterization." Atherosclerosis vol. 339 (2021): 12-19. doi: https://doi.org/10.1016/j.atherosclerosis.2021.11.011
Gremmel T, Michelson AD, Wadowski PP, Pultar J, Weikert C, Tscharre M, Lee S, Panzer S, Frelinger AL. Sex-specific platelet activation through protease-activated receptor-1 in patients undergoing cardiac catheterization. Atherosclerosis. 2021 Dec;339:12-19. doi: 10.1016/j.atherosclerosis.2021.11.011. Epub 2021 Nov 12. PMID: 34808540.
Copy Download .nbib Format: NLM
Share it on

Atherosclerosis. 2021 Dec;339:12-19. doi: 10.1016/j.atherosclerosis.2021.11.011. Epub 2021 Nov 12.

Sex-specific platelet activation through protease-activated receptor-1 in patients undergoing cardiac catheterization.

Atherosclerosis

Thomas Gremmel, Alan D Michelson, Patricia P Wadowski, Joseph Pultar, Constantin Weikert, Maximilian Tscharre, Silvia Lee, Simon Panzer, Andrew L Frelinger

Affiliations

  1. Center for Platelet Research Studies, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA; Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria; Institute of Antithrombotic Therapy in Cardiovascular Disease, Karl Landsteiner Society, St. Poelten, Austria; Department of Internal Medicine I, Cardiology and Intensive Care Medicine, Landesklinikum Mistelbach-Gänserndorf, Mistelbach, Austria. Electronic address: [email protected].
  2. Center for Platelet Research Studies, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA.
  3. Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.
  4. Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria.

PMID: 34808540 DOI: 10.1016/j.atherosclerosis.2021.11.011

Abstract

BACKGROUND AND AIMS: Protease-activated receptor (PAR)-1-mediated platelet activation may vary according to sex and clinical situation. In order to investigate sex-specific platelet activation through PAR-1, we assessed platelet response to thrombin receptor-activating peptide (TRAP) in 562 patients undergoing cardiac catheterization without (Group 1A) and with (Group 1B) acute coronary syndrome (ACS). Subsequently, we sought to confirm our findings in 287 patients undergoing elective (Group 2A) or acute (Group 2B) percutaneous coronary intervention.

METHODS: TRAP-stimulated platelet surface expression of P-selectin and activated glycoprotein IIb/IIIa (GPIIb/IIIa) were measured by flow cytometry in Group 1. Light transmission aggregometry (LTA) and multiple electrode aggregometry (MEA) in response to TRAP were assessed in Group 2.

RESULTS: In Group 1A, platelet activation in response to TRAP was significantly higher in women compared to men (P-selectin: 511 MFI [443-597 MFI] vs. 471 MFI [393-552 MFI]; GPIIb/IIIa: 84 MFI [58-119 MFI] vs. 70 MFI [47-103 MFI]; both p ≤ 0.002). In contrast, in Group 1B, TRAP-stimulated P-selectin and activated GPIIb/IIIa were similar in men and women (both p ≥ 0.3). Likewise, TRAP-stimulated platelet aggregation was significantly higher in female patients in Group 2A (LTA: 66% [54-76%] vs. 51% [41-65%]; MEA: 78 AU [66-107 AU] vs. 62 AU [52-88 AU]; both p ≤ 0.02), whereas men and women in Group 2 B had similar platelet aggregation (p = 0.5). The occurrence of ischemic endpoints did not differ significantly between men and women in Group 1A and Group 1B.

CONCLUSIONS: Platelet PAR-1 signaling is more pronounced in women than in men without ACS. In ACS, however, PAR-1-mediated platelet activation is similar in male and female patients.

Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Keywords: Acute coronary syndrome; Cardiac catheterization; Platelet activation; Protease-activated receptor-1; Sex

Publication Types